AI vs. high blood pressure: smart software aims to personalize treatment

NCT ID NCT06828692

Recruiting now Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Feb 21, 2026 · Last updated Jun 12, 2026 · Updated 17 times

Summary

This study tests whether a computer program that uses machine learning can help doctors choose the best blood pressure medications for each patient. About 2,160 adults with high blood pressure will be enrolled across 51 clinics in China. Some clinics will use the computer program to guide treatment, while others will use standard care. The goal is to see if the program helps more patients reach a safe blood pressure level faster and with fewer or lower-dose pills.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Fuwai Shenzhen Hospital, Chinese Academy of Medical Sciences
RECRUITING

Shenzhen, Shenzhen, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HYPERTENSION